Naoki Hosogaya

593 total citations
49 papers, 301 citations indexed

About

Naoki Hosogaya is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, Naoki Hosogaya has authored 49 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 20 papers in Infectious Diseases and 7 papers in Physiology. Recurrent topics in Naoki Hosogaya's work include Antifungal resistance and susceptibility (13 papers), Influenza Virus Research Studies (8 papers) and Fungal Infections and Studies (8 papers). Naoki Hosogaya is often cited by papers focused on Antifungal resistance and susceptibility (13 papers), Influenza Virus Research Studies (8 papers) and Fungal Infections and Studies (8 papers). Naoki Hosogaya collaborates with scholars based in Japan, United States and France. Naoki Hosogaya's co-authors include Takahiro Takazono, Hiroshi Mukae, Katsunori Yanagihara, Koichi Izumikawa, Taiga Miyazaki, Masato Tashiro, Yoshifumi Imamura, Shigeru Kohno, Shigeki Nakamura and Hiroshi Kakeya and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Naoki Hosogaya

42 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Hosogaya Japan 10 164 152 53 41 27 49 301
Fengyao Wu China 8 133 0.8× 140 0.9× 46 0.9× 17 0.4× 36 1.3× 13 273
Lore Vanderbeke Belgium 9 299 1.8× 186 1.2× 41 0.8× 59 1.4× 42 1.6× 13 373
Shotaro Ide Japan 8 180 1.1× 179 1.2× 30 0.6× 76 1.9× 15 0.6× 35 288
Hideki Ikeda Japan 9 81 0.5× 86 0.6× 42 0.8× 45 1.1× 24 0.9× 33 247
Qiaoyang Lu United States 8 241 1.5× 201 1.3× 52 1.0× 33 0.8× 11 0.4× 15 346
Zoe Weiss United States 10 134 0.8× 165 1.1× 18 0.3× 34 0.8× 11 0.4× 24 278
Joy Logan United States 10 129 0.8× 201 1.3× 27 0.5× 25 0.6× 16 0.6× 18 338
Chivonne Moodley United States 9 212 1.3× 174 1.1× 86 1.6× 19 0.5× 69 2.6× 14 343
Yanhua Pang China 11 135 0.8× 191 1.3× 88 1.7× 16 0.4× 41 1.5× 17 374
Vijay Harypursat China 12 289 1.8× 119 0.8× 92 1.7× 34 0.8× 31 1.1× 41 452

Countries citing papers authored by Naoki Hosogaya

Since Specialization
Citations

This map shows the geographic impact of Naoki Hosogaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Hosogaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Hosogaya more than expected).

Fields of papers citing papers by Naoki Hosogaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Hosogaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Hosogaya. The network helps show where Naoki Hosogaya may publish in the future.

Co-authorship network of co-authors of Naoki Hosogaya

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Hosogaya. A scholar is included among the top collaborators of Naoki Hosogaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Hosogaya. Naoki Hosogaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwanaga, Naoki, Tatsuro Hirayama, Masataka Yoshida, et al.. (2025). Prevotella intermedia Synergistically Exacerbates Pneumonia Induced by Oral Streptococci. The Journal of Infectious Diseases. 232(2). e280–e289.
3.
Takazono, Takahiro, Shotaro Ide, Y. Ogata, et al.. (2025). Risk Factors and Prognostic Effects of Aspergillosis as a Complication of Nontuberculous Mycobacterial Pulmonary Disease: A Nested Case–Control Study. Mycoses. 68(1). e70022–e70022. 2 indexed citations
5.
Fukui, Shoichi, Remi Sumiyoshi, Tomohiro Koga, et al.. (2025). A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease. Cureus. 17(2). e78865–e78865.
6.
Takazono, Takahiro, et al.. (2024). Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B. Influenza and Other Respiratory Viruses. 18(9). e70002–e70002. 2 indexed citations
7.
Takazono, Takahiro, Masato Tashiro, Shotaro Ide, et al.. (2024). Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis. Infectious Diseases and Therapy. 14(1). 245–259. 1 indexed citations
8.
Iwanaga, Naoki, Yuya Ito, Tatsuro Hirayama, et al.. (2024). Neglected Pulmonary Infection Caused by Exophiala dermatitidis Misidentified as Rhodotorula spp.. Mycoses. 67(10). e13804–e13804. 1 indexed citations
9.
Iwanaga, Naoki, Yuya Ito, Tatsuro Hirayama, et al.. (2024). Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells. Antibiotics. 13(9). 909–909. 1 indexed citations
10.
Takazono, Takahiro, Shimpei Morimoto, Yuya Ito, et al.. (2023). The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database. Mycoses. 67(1). e13658–e13658. 7 indexed citations
11.
Iwanaga, Naoki, Yuya Ito, Nobuyuki Ashizawa, et al.. (2023). Pulmonary phaeohyphomycosis due to Exophiala dermatitidis in a patient with pulmonary non-tuberculous mycobacterial infection. Journal of Infection and Chemotherapy. 29(6). 615–619. 4 indexed citations
12.
Ito, Yuya, Yasushi Obase, Takahiro Takazono, et al.. (2023). Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis. Internal Medicine. 63(11). 1659–1664. 1 indexed citations
13.
Takazono, Takahiro, et al.. (2023). Impact of meteorological and demographic factors on the influenza epidemic in Japan: a large observational database study. Scientific Reports. 13(1). 13000–13000. 2 indexed citations
14.
Takao, Daisuke, Takahiro Takazono, Yuya Ito, et al.. (2023). A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension. Journal of Infection and Chemotherapy. 29(8). 806–808. 3 indexed citations
15.
Takazono, Takahiro, Shimpei Morimoto, Masato Tashiro, et al.. (2022). Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study. Mycoses. 65(9). 897–902. 3 indexed citations
16.
Sakamoto, Noriho, Naoki Hamada, Masaki Okamoto, et al.. (2021). Efficacy and safety of nintedanib in Japanese patients with early-stage idiopathic pulmonary fibrosis: a study protocol for an observational study. BMJ Open. 11(6). e047249–e047249. 2 indexed citations
19.
Koga, Tomohiro, Shuntaro Sato, Naoki Hosogaya, et al.. (2020). An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance. Medicine. 99(1). e18328–e18328. 9 indexed citations
20.
Takazono, Takahiro, Naoki Hosogaya, Masakazu Fujiwara, et al.. (2020). Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study. Clinical Infectious Diseases. 72(11). e859–e867. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026